As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

EDMONTON, AB, February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to ...

EDMONTON, AB, February 6, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to announce a ...

Aurora Cannabis (ACB) stock jumped 45% on strong earnings, driven by record medical cannabis sales. CGC, TLRY and CRON also gained as the sector rallied on Aurora’s performance and trade tariff ...

The term of the agreement is for three years with an option to extend and an estimated value of $27 million. EDMONTON — Aurora Cannabis signs a supply agreement with SNDL, a Canadian licensed ...

Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35. The company has a market capitalization of $330.81 million, a PE ratio of -7.93 and a beta of 1.85.

Shares of Aurora Cannabis and other cannabis companies saw significant buying on Wednesday following Aurora’s quarterly earnings report. For its most recent quarter, Aurora reported total net ...

Investing.com -- Shares of Aurora Cannabis Inc. (NASDAQ: NASDAQ:ACB) (TSX: ACB) soared 40% following the announcement of its fiscal 2025 third-quarter results. The Edmonton-based company reported ...

Aurora Cannabis reported Q3 FY25 net revenue of CA$88.2M, driven by rise in medical cannabis sales and plant propagation. Adjusted EBITDA surged 316% to CA$23.1M, with adjusted gross margin ...